Hemophilia A or B

Clinical trials for Hemophilia A or B explained in plain language.

Never miss a new study

Get alerted when new Hemophilia A or B trials appear

Sign up with your email to follow new studies for Hemophilia A or B, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1 Not yet finished but already full! 1

New weekly shot aims to prevent bleeding in hemophilia patients

Disease control Recruiting now

This Phase 3 study is testing a drug called KN057, given as a weekly injection under the skin, to prevent bleeding in people with hemophilia A or B (with or without inhibitors). The trial will enroll 70 males aged 12 to 65 and will monitor safety and how well the drug works over …

Matched conditions: HEMOPHILIA A OR B

Phase 3 • Sponsor: Suzhou Alphamab Co., Ltd. • Aim: Disease control

Last updated Jun 27, 2026 12:23 UTC

Hemophilia A or B

Get alerted when new Hemophilia A or B trials appear

New weekly shot aims to prevent bleeding in hemophilia patients